WHO naming stem · infix · 31 listed names
-grel-/-grel
This page was written with AI.
platelet aggregation inhibitors
Where it sits in a name
WHO writes the stem as -grel-/-grel. It has 2 spellings or places: grel inside the name, with letters before and after it (…grel…); grel at the end of the name (…grel).
Of the 31 names WHO lists under it, 10 carry grel inside the name, with letters before and after it, 21 carry grel at the end of the name.
All 31 names WHO lists under -grel-/-grel
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 5 of 31 names appear in these lists: 5 in the US list (FDA Drugs@FDA) and 5 in the EU central list (EMA); 4 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- anagrelideUS brands: AGRYLIN
- camonagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cangrelorUS brands: KENGREALEU (central) brands: Kengrexal
- clopidogrelUS brands: PLAVIXEU (central) brands: Clopidogrel BGR, Clopidogrel HCS, Clopidogrel Krka, Clopidogrel Krka d.d., Clopidogrel ratiopharm, Clopidogrel TAD, Clopidogrel Taw Pharma, Clopidogrel Teva (hydrogen sulphate), Clopidogrel Viatris, Clopidogrel Zentiva, Grepid, Iscover
15 more
Plavix, Zyllt, Clopidogrel 1A Pharma (withdrawn), Clopidogrel Acino (withdrawn), Clopidogrel Acino Pharma (withdrawn), Clopidogrel Acino Pharma GmbH (withdrawn), Clopidogrel BMS (withdrawn), Clopidogrel DURA (withdrawn), Clopidogrel Hexal (withdrawn), Clopidogrel Qualimed (withdrawn), Clopidogrel ratiopharm GmbH (withdrawn), Clopidogrel Sandoz (withdrawn), Clopidogrel Teva Generics B.V. (lapsed), Clopidogrel Teva Pharma (withdrawn), Clopidogrel Teva Pharma B.V. (withdrawn)in combination: Clopidogrel / Acetylsalicylic acid Viatris with acetylsalicylic acid; Clopidogrel/Acetylsalicylic acid Zentiva with acetylsalicylic acid; DuoPlavin with acetylsalicylic acid; Clopidogrel/Acetylsalicylic acid Teva (withdrawn) with acetylsalicylic acid - dazmegrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elinogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- furegrelateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- isbogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- itazigrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- midazogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nafagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- nicogrelateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- oxagrelateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ozagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pamicogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- parogrelilNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pirmagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- prasugrelUS brands: EFFIENT
- rafigrelideNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- regrelorNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ridogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rolafagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- samixogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sarpogrelateNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- satigrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- selatogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sunagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- temanogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- terbogrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- ticagrelorUS brands: BRILINTA
- trifenagrelNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
ozagrel
Listed INNCarries the WHO stem -grel-/-grel
- -grel-/-grelend of the nameWHO lists it hereWHO definition: platelet aggregation inhibitors
“ozagrel” is an INN that WHO lists under -grel-/-grel in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -grel-/-grel (Part II B) and the 31 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.